Multiply Labs develops advanced robotic systems that manufacture individualized drugs at scale. Our products are enabled by the combination of pharmaceutical science with robotics technology.

Multiply Labs has built and operates a unique robotic pharmaceutical manufacturing facility in San Francisco.

TechU Ventures

P101

Graph Ventures

Lux Capital

Casdin Capital

Pathfinder

Fifty Years

Founders Fund

Garage Capital

Alice Zhang

Multiply Labs

Multiply Labs is excited to announce a successful Proof-of-Concept of Robotic Cell Therapy Manufacturing in collaboration with industry leaders University of California, San Francisco, Cytiva, Thermo Fisher Scientific and Charles River Laboratories. Read more about the collaboration to demonstrate automated cell therapy manufacturing tasks, with an emphasis on cell expansion, and the successful proof-of-concept!

#robotics #manufacturing #pharma #celltherapy

It was a pleasure to be a guest on Inès Makula and Camilla Scassellati Sforzolini's show, Made IT Podcast, talking about how Multiply Labs is growing as a robotics startup in the pharmaceutical space!

Click on the link below to listen to the podcast in Italian and for a full transcript for translation: https://lnkd.in/gcvch8VU 

Our Robotic Clusters for cell therapy manufacturing are designed to fit into any existing facility, without needing retrofits. The minimum ceiling height requirement to deploy Multiply Labs' systems is just 8 feet - making the Robotic Cluster compatible with all modern cell therapy facility layouts, including prefabricated clean rooms and pods. 

Follow us on LinkedIn and reach out at info@multiplylabs.com to learn more or for a demo.

#robotics #manufacturing #pharma 

Read this article to learn more about how our technology tackles the current problems in cell and gene therapy manufacturing!
Follow us on LinkedIn and reach out at info@multiplylabs.com to learn more, or for a demo.
#robotics #manufacturing #pharma 

Multiply Labs software systems generate digital records that are designed to ensure the safety and quality of individualized pharmaceutical products. Hear from Varun Bhatia how our systems enable 100% in-process quality control by automatically filling out digital records.

Follow us on LinkedIn and reach out at info@multiplylabs.com to learn more, or for a demo.

#robotics #manufacturing #pharmaceutical 

Aprecia specializes in 3D printing technology for pharmaceuticals.

Aprecia

FabRx is a company focused on developing 3D printing technology for personalized medicine, including pharmaceutical capsules.

FabRx

think3D is a provider of 3D printing solutions, including applications in pharmaceutical manufacturing.

think3D

Speckodyne Corp focuses on continuous real-time blood coagulability monitoring technology for medical settings.

Speckodyne

Cellares provides a cell therapy manufacturing technology platform for clinical and industrial-scale cell therapy manufacturing.

Cellares

Multiply Labs is a robotics company that specializes in developing robotic manufacturing platforms for the pharmaceutical industry. Their robots are designed to automate and streamline the production of precision medicines, capsules, and cell therapies, aiming to improve efficiency and reduce labor-intensive processes.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Feb 23, 2024 4:05 PM	04804d27
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Feb 23, 2024 4:05 PM	34bc70c6
company summary	general
signals	general
crunchbase trigger	general	Nov 12, 2024 12:52 PM	70cc8c2b
crunchbase profile	general
li profile	general	Feb 23, 2024 4:05 PM	4c82c170
translate crunchbase fundingrounds	general
peers	general
news basic	general	Feb 23, 2024 4:05 PM	2052ec84
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:MULTIPLYLABS

Multiply Labs